LBF20115PG05: Difference between revisions
No edit summary |
No edit summary |
||
(13 intermediate revisions by 2 users not shown) | |||
Line 6: | Line 6: | ||
|LipidBank=XPR1789 | |LipidBank=XPR1789 | ||
|LipidMaps=- | |LipidMaps=- | ||
|SysName= | |SysName=(9alpha,11alpha)-Dihydroxy-15-oxo- (8beta) -prost-cis-5-en-1-oic acid | ||
|Common Name=&&8-iso-13,14-dihydro-15-keto Prostaglandin | |Common Name=&&8-iso-13,14-dihydro-15-keto Prostaglandin F_2 alpha&&(9alpha,11alpha)-Dihydroxy-15-oxo- (8beta) -prost-5(Z)-en-1-oic acid&& | ||
|Source= | |Source= | ||
|Chemical Synthesis= | |Chemical Synthesis= | ||
|Metabolism= | |Metabolism= | ||
|Biological Activity=8-iso-13,14-dihydro-15-keto PGF2 alpha weakly has been reported to inhibit the U-46619 or collagen-induced platelet aggregation.[[Reference:Cranshaw_JH:Evans_TW:Mitchell_JA:,Br. J. Pharmacol.,2001,132,1699|{{RelationTable/GetFirstAuthor|Reference:Cranshaw_JH:Evans_TW:Mitchell_JA:,Br. J. Pharmacol.,2001,132,1699}}]] | |||
}} | }} | ||
{{Lipid/Footer}} | {{Lipid/Footer}} |
Latest revision as of 08:19, 21 October 2010
LipidBank Top (トップ) |
Fatty acid (脂肪酸) |
Glycerolipid (グリセロ脂質) |
Sphingolipid (スフィンゴ脂質) |
Journals (雑誌一覧) |
How to edit (ページの書き方) |
IDs and Links | |
---|---|
LipidBank | XPR1789 |
LipidMaps | - |
CAS | |
KEGG | {{{KEGG}}} |
KNApSAcK | {{{KNApSAcK}}} |
mol | LBF20115PG05 |
8-iso-13,14-dihydro-15-keto Prostaglandin F2α | |
---|---|
Structural Information | |
(9α,11α)-Dihydroxy-15-oxo- (8β) -prost-cis-5-en-1-oic acid | |
| |
Formula | C20H34O5 |
Exact Mass | 354.240624198 |
Average Mass | 354.48096000000004 |
SMILES | C(CCC(=O)CC[C@H]([C@@H]1CC=CCCCC(O)=O)[C@@H](C[C@@H]1O)O)CC |
Physicochemical Information | |
8-iso-13,14-dihydro-15-keto PGF2 alpha weakly has been reported to inhibit the U-46619 or collagen-induced platelet aggregation. Cranshaw_JH et al. | |
Spectral Information | |
Mass Spectra | |
UV Spectra | |
IR Spectra | |
NMR Spectra | |
Other Spectra | |
Chromatograms |
Reported Metabolites, References | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|
|